Dr. Christopher Jennings, MD

NPI: 1801839485
Total Payments
$1.4M
2024 Payments
$42,000
Companies
6
Transactions
1,026

Payment Breakdown by Category

Consulting$1.4M (100.0%)
Food & Beverage$178.69 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1.4M 1,017 100.0%
Food and Beverage $178.69 9 0.0%

Top Paying Companies

Company Total Records Latest Year
CSL Behring $1.1M 883 $0 (2022)
Kedplasma LLC $211,400 73 $0 (2024)
CSL Plasma Inc. $72,600 61 $0 (2023)
ABBVIE INC. $102.00 5 $0 (2023)
MannKind Corporation $62.54 3 $0 (2018)
Boston Scientific Corporation $14.15 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $42,000 12 Kedplasma LLC ($42,000)
2023 $116,102 80 CSL Plasma Inc. ($72,600)
2022 $280,291 218 CSL Behring ($246,691)
2021 $276,071 214 CSL Behring ($242,471)
2020 $274,250 215 CSL Behring ($243,450)
2019 $237,639 189 CSL Behring ($209,625)
2018 $128,475 94 CSL Behring ($128,413)
2017 $7,063 4 CSL Behring ($7,063)

All Payment Transactions

1,026 individual payment records from CMS Open Payments — Page 1 of 42

Date Company Product Nature Form Amount Type
12/31/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
11/29/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
10/31/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
09/30/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
08/30/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
07/31/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
06/28/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
05/31/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
04/30/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
03/29/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
02/29/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
01/31/2024 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
12/29/2023 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
11/30/2023 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
11/08/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.02 General
Category: NEUROSCIENCE
10/31/2023 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
10/06/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.11 General
Category: NEUROSCIENCE
09/29/2023 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
08/31/2023 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
08/15/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.80 General
Category: NEUROSCIENCE
08/09/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.57 General
Category: NEUROSCIENCE
07/31/2023 Kedplasma LLC Consulting Fee Cash or cash equivalent $3,500.00 General
07/19/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $27.50 General
Category: NEUROSCIENCE
07/01/2023 Kedplasma LLC Consulting Fee Cash or cash equivalent $2,800.00 General
06/21/2023 Kedplasma LLC Consulting Fee Cash or cash equivalent $2,800.00 General

About Dr. Christopher Jennings, MD

Dr. Christopher Jennings, MD is a Internal Medicine healthcare provider based in Anderson, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801839485.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Jennings, MD has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $42,000 received in 2024. These payments were reported across 1,026 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($1.4M).

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Obstetrics & Gynecology
  • Location Anderson, SC
  • Active Since 06/13/2006
  • Last Updated 12/13/2023
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1801839485

Products in Payments

  • VRAYLAR (Drug) $102.00
  • AFREZZA (Drug) $62.54
  • GENERAL PAIN MANAGEMENT (Device) $14.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Anderson